FDA Okays Historic Blood Treatment for COVID; Clinical Trials to Use Antibodies From Recovered Patients

FDA Okays Historic Blood Treatment for COVID; Clinical Trials to Use Antibodies From Recovered Patients

As the U.S. Food and Drug Administration (FDA) works to facilitate expedited access to several investigative drug interventions to treat COVID-19 patients, one particularly promising treatment is now set to enter clinical trials in New York. The convalescent plasma treatment involves drawing blood plasma out of an individual who has … Read more